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Background:  Infiltrative cardiomyopathy is an uncommon cause of systolic or diastolic dysfunction and progressive heart failure (HF). 
Early diagnosis and treatment can be achieved by careful clinical exam and non-invasive tests, but tissue diagnosis remains important 
when considering chemotherapy options.
case:  A 60 years-old gentleman was admitted for the second time in two months for dyspnea. He had a history of hypertension, idiopathic 
patchy motor neuropathic progress for 2 months, dysphagia and voice hoarseness for 6 months, and cryptomeningitis 10 years ago. 
Physical examination revealed a cachectic man with a jugular venous pressure of 8cm above the sternal angle, a normal S1 and S2, an 
S3, no murmurs, and decreased breath sounds to the mid right lung field. His EKG showed a normal sinus rhythm with low voltages. An 
echocardiogram showed significant biventricular hypertrophy and a depressed ejection fraction of 20%.
decision Making:  The constellation of heart failure symptoms, unilateral pleural effusion, and increased wall thickness with a well 
controlled blood pressure were highly suggestive of an infiltrative cardiomyopathy. In particular, low voltages on EKG made amyloid most 
suspicious. A fat aspiration biopsy was negative for amyloid deposition. The patient improved with diuresis. Infectious work-up and further 
neurologic imaging were non-revealing. The constellation of neuropathy and unexplained systolic dysfunction, clinical suspicion remained 
high for amyloid. A fat pad block biopsy was therefore planned prior to further cardiac tests; it was positive for amyloid light-chanin subtype 
amyloidosis by Congo Red stain. A cardiac CT was done and showed subendocardial delayed gadolinium enhancement in a pattern 
consistent with amyloid; this was deemed enough evidence of amyloid cardiomyopathy in the right clinical setting and a right ventricular 
biopsy was not performed. He was started on bortezomid and prednisone. With chemotherapy, he has had improvement in his energy 
levels and HF symptoms.
conclusion:  This case demonstrates that sequential and sometimes repetitive testing may be required to diagnosed infiltrative 
cardiomyopathies, in this case amyloid.
